Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?

Detalles Bibliográficos
Autores principales: Gribben, John G., de Vries, Elisabeth, Cherny, Nathan I., Sonneveld, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162084/
https://www.ncbi.nlm.nih.gov/pubmed/32309790
http://dx.doi.org/10.1097/HS9.0000000000000354
_version_ 1783523020042665984
author Gribben, John G.
de Vries, Elisabeth
Cherny, Nathan I.
Sonneveld, Pieter
author_facet Gribben, John G.
de Vries, Elisabeth
Cherny, Nathan I.
Sonneveld, Pieter
author_sort Gribben, John G.
collection PubMed
description
format Online
Article
Text
id pubmed-7162084
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-71620842020-04-17 Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next? Gribben, John G. de Vries, Elisabeth Cherny, Nathan I. Sonneveld, Pieter Hemasphere Editorial Wolters Kluwer Health 2020-04-01 /pmc/articles/PMC7162084/ /pubmed/32309790 http://dx.doi.org/10.1097/HS9.0000000000000354 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Editorial
Gribben, John G.
de Vries, Elisabeth
Cherny, Nathan I.
Sonneveld, Pieter
Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title_full Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title_fullStr Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title_full_unstemmed Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title_short Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
title_sort measuring clinical benefit of treatments for hematologic malignancies: critical first steps accomplished—what is next?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162084/
https://www.ncbi.nlm.nih.gov/pubmed/32309790
http://dx.doi.org/10.1097/HS9.0000000000000354
work_keys_str_mv AT gribbenjohng measuringclinicalbenefitoftreatmentsforhematologicmalignanciescriticalfirststepsaccomplishedwhatisnext
AT devrieselisabeth measuringclinicalbenefitoftreatmentsforhematologicmalignanciescriticalfirststepsaccomplishedwhatisnext
AT chernynathani measuringclinicalbenefitoftreatmentsforhematologicmalignanciescriticalfirststepsaccomplishedwhatisnext
AT sonneveldpieter measuringclinicalbenefitoftreatmentsforhematologicmalignanciescriticalfirststepsaccomplishedwhatisnext

Ejemplares similares